Mizuho analyst Dan Dolev raised the firm’s price target on Cognizant (CTSH) to $87 from $85 and keeps a Neutral rating on the shares post the Q4 report. The company reported strong results led by Financial Services and provided solid 2026 guidance, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTSH:
- Cognizant partners with Palantir for AI-driven modernization in healthcare
- Cognizant price target raised to $88 from $82 at RBC Capital
- Cognizant price target lowered to $85 from $86 at TD Cowen
- Cognizant price target raised to $82 from $80 at Morgan Stanley
- Cognizant: Solid Execution, Strong Bookings, and Strategic AI Positioning Underpin Buy Rating